Skip to content

Mindfulness Based Compassionate Living in Recurrent Depression

The Effectiveness of Mindfulness Based Compassionate Living in Recurrent Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02059200
Acronym
MBCL-RD
Enrollment
122
Registered
2014-02-11
Start date
2013-07-31
Completion date
2015-11-30
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Depression

Keywords

Randomised controlled trial, Recurrent depression, Mindfulness training, Compassion training (MBCL), Fear of Compassion, Added value Compassion

Brief summary

Since a few years, Mindfulness Based Cognitive Therapy (MBCT) has been used as treatment for patients suffering from recurrent depression. Though a number of studies show that MBCT is effective in this population and MBCT reduces the chances of relapse/recurrence in recurrent depressive patients, the chance of a new depression developing after end of treatment is still considerable. Ergo, there is room for improvement. Especially the development of a non-judging or compassionate attitude towards all experience seems to mediate the treatment effect. It is therefore our expectation that a follow-up intervention that focuses specifically on self-compassion could prove very useful in elaborating on the effects of MBCT. The research question of this research is therefore: what is the effect of compassion training in people suffering from recurrent depression who have already received MBCT training?

Interventions

BEHAVIORALMindfulness Based Compassionate Living

The MBCL program consists of eight biweekly group sessions of 2.5 hours, in which the participants get formal meditation exercises, some theoretical information and participate in inquiry on the meditation exercises and homework assignments. Homework assignments are given after every session, consisting of formal and informal meditation exercises primarily and some diary instructions.

Sponsors

Triodos Foundation
CollaboratorUNKNOWN
Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Recurrent depression according to the DSM-IV criteria. 2. Having participated in an MBCT training (\>= 4 sessions)

Exclusion criteria

1. One or more previous (hypo)manic episodes according to DSM-IV criteria. 2. Primary psychotic disorder, e.g. schizophrenia or delusions. 3. Clinically relevant neurological conditions (e.g. brain trauma or dementia) or somatic conditions (e.g. cancer, AIDS) that could be related to the depression. 4. Current alcohol and/or drug abuse. 5. Use of high dosages of benzodiazepines. 6. Recent electro convulsive therapy (ECT) (less than 3 months ago). 7. Problems impeding participating in a group, such as severe borderline personality disorder. 8. No prior experience with MBCT. 9. Problems impeding completing the questionnaires, such as cognitive dysfunctions (only assessed if suspected). 10. Subnormal intelligence (IQ \< 80) (only assessed if suspected).

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory-II1 yearThe BDI-II measures depression symptoms. Measurements will be taken at baseline, end of treatment/control and follow up.

Secondary

MeasureTime frameDescription
Five Facet Mindfulness Questionnaire1 yearThe FFMQ measures mindfulness skills. Measurements will be taken at baseline, end of treatment/control and follow-up.
The Acceptance and Action Questionnaire-II1 yearThe AAQ-II measures Experiential Avoidance. Measurements will be taken at baseline, end of treatment/control and follow-up.
Fears of Compassion Scale (3)1 yearThe FoCS (3) measures fear of Self-Compassion. Measurements will be taken at baseline, end of treatment/control and follow-up.
Self-Compassion Scale1 yearThe Self-Compassion Scale measures Self-Compassion. Measurements will be taken at baseline, end of treatment/control and follow-up.
The World Health Organization Quality of Life Scale1 yearThe WHO-QoL measures Quality of Life. Measurements will be taken at baseline, end of treatment/control and follow-up.
The Ruminative Response Scale1 yearThe RRS measures Rumination. Measurements will be taken at baseline, end of treatment/control and follow-up.
The Childhood Trauma QuestionnaireBaselineThe CTQ measures Childhood Adversity. Measurements will be taken at baseline only.
Types of Positive Affect Scale1 yearThe TPAS measures Positive Affect. Measurements will be taken at baseline, end of treatment/control and follow-up.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026